LuciCeno 12.5 mg tablets contain cenobamate, an antiseizure medicine. It is used for the treatment of partial-onset (focal) seizures in

LuciCeno 50 mg tablets contain cenobamate, an antiseizure medicine. It is used for the treatment of partial-onset (focal) seizures in

LuciNfig 25 mg capsules contain infigratinib, an FGFR kinase inhibitor. It was developed for previously treated, unresectable locally advanced or

LuciRevu 110 mg tablets contain revumenib, a menin inhibitor. It is used for relapsed or refractory acute leukaemia with a

LuciRevu 25 mg tablets contain revumenib, a menin inhibitor. It is used for relapsed or refractory acute leukaemia with a

LuciTala 0.25 mg capsules contain talazoparib, a PARP inhibitor. It is used for germline BRCA-mutated, HER2-negative locally advanced or metastatic

LuciVande 100 mg tablets contain vandetanib, a kinase inhibitor of RET, VEGFR and EGFR. It is used for symptomatic or